The Tools and Levers of Access to Patented Health Related Genetic Invention in Canada

Abstract

This Article argues that there is a prevailing problem of access to genetic invention in Canada caused by disputes over intellectual property rights arising from conflicting normative orders.

Keywords

Patents -- Canada, Genetics, Health care industry -- Canada, Health care industry -- Law & legislation, Gene therapy, Generic drugs, Health care services accessibility, Patent licensing, Bayh-Dole Act, Canada, United States

Share

Authors

S. Tina Piper (McGill University)

Download

Issue

Publication details

Dates

Licence

All rights reserved

Peer Review

This article has not been peer reviewed.

File Checksums (MD5)

  • pdf: 84477d1730407b13eda0e64bd4425e93